CBO Sets $158 Million Price Tag For Breakthrough Devices In Cures Bill
This article was originally published in The Gray Sheet
Executive Summary
The Congressional Budget Office estimates that the cost of all FDA device provisions, including a breakthrough device pathway, in the House 21st Century Cures bill would be $299 million, a significant chunk of the total costs for FDA provisions in the bill.